<p>在 2025 年 10 月，全球市场正面临一个复杂的局面，特点是美国通胀低于预期、国债收益率波动，以及欧元区和中国等关键地区的商业活动增强。在这些发展中，投资者越来越关注内部持股比例高的成长型公司，作为在不确定经济环境中寻求稳定和韧性的潜在途径。</p>
<h3>全球内部持股比例高的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>锐明技术 (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>84.6%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.9%</td>
<td>43.9%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>30.3%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>34.2%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>69.2%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>24.9%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>35.2%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>49.6%</td>
</tr>
<tr>
<td>Ascentage Pharma Group International (SEHK:6855)</td>
<td>12.8%</td>
<td>91.9%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们筛选出的 819 只内部持股比例高的快速成长全球公司的完整名单。</p>
<p>以下是我们筛选出的部分股票。</p>
<h2>江苏微导纳米设备科技 (SHSE:688147)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 江苏微导纳米设备科技有限公司专注于制造高端微纳米设备，服务于半导体及泛半导体行业，市值为 244 亿元人民币。</p>
<p><strong>运营：</strong> 公司通过设备制造部门产生收入，专注于半导体及泛半导体领域的高端微纳米设备。</p>
<p><strong>内部持股比例：</strong> 18.7%</p>
<p>江苏微导纳米设备科技展现出强劲的增长潜力，预计未来三年收益将显著增长。公司的收入预计将以 22.7% 的年率增长，超过中国市场的平均水平。尽管市盈率高达 68.7 倍，但仍低于半导体行业的平均水平 80.6 倍。最近的财务表现显示出显著改善，2025 年上半年净收入从去年的 4285 万元上升至 1.9236 亿元，突显出其在股价波动和完成总计 7953 万元的股票回购中的增长轨迹。</p>
<ul>
<li>通过我们的综合分析师估计报告深入了解江苏微导纳米设备科技的复杂性。</li>
<li>我们最近的估值报告指出，江苏微导纳米设备科技的股票在市场上可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b4b45422-b4d0-4f2a-8c1b-61597995333c/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b4b45422-b4d0-4f2a-8c1b-61597995333c/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:688147 截至 2025 年 10 月的收益和收入增长</p>
<h2>北京君正半导体有限公司 (SZSE:300223)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 北京君正半导体有限公司专注于集成电路芯片产品的研发、设计和销售，业务覆盖中国及国际市场，市值为 434.2 亿元人民币。</p>
<p><strong>运营：</strong> 北京君正半导体有限公司通过在国内外市场的集成电路芯片产品的研发、设计和销售产生收入。</p>
<p><strong>内部持股比例：</strong> 16%</p>
<p>北京君正半导体有限公司展现出潜力，预计收益将以 26.43% 的年率显著增长，超过中国市场的平均水平。然而，其股价近期波动较大。尽管如此，最近对公司章程的修订和在香港进行 H 股发行的计划表明了战略增长的举措。公司的 2025 年半年度财务数据显示，收入和净收入分别小幅增长至 22.5 亿元和 2.0312 亿元，表明在这些发展中的稳定表现。</p>
<ul>
<li>在我们的收益增长报告中更深入地了解北京君正半导体有限公司的潜力。</li>
<li>我们的北京君正半导体有限公司估值报告中的分析暗示其股价相较于估计价值被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/acde7488-b0a5-45e4-9f1d-446e3fdc5877/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/acde7488-b0a5-45e4-9f1d-446e3fdc5877/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300223 截至 2025 年 10 月的收益和收入增长</p>
<h2>Chroma ATE (TWSE:2360)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Chroma ATE Inc.是一家设计、组装、制造、销售、维修和维护各种软件和硬件产品的公司，包括计算机自动测试系统和电子测试仪器，业务遍及台湾、中国、美国及国际市场；市值为 2931.8 亿新台币。</p>
<p><strong>运营：</strong> 公司的收入主要来自其测量仪器业务，产生 397.7 亿新台币，以及自动化运输工程，贡献 13.2 亿新台币。</p>
<p><strong>内部持股比例：</strong> 14.6%</p>
<p>Chroma ATE 的增长轨迹通过预计年收益增长 19.24% 得以体现，超过台湾市场的平均水平。尽管近期股价波动较大，但其 2025 年第二季度的强劲财务表现——收入上升至 64.6 亿新台币，净收入达到 19.5 亿新台币——显示出韧性。尽管内部交易活动保持稳定，没有显著的买入或卖出，但公司在三年内保持 32.5% 的强劲股本回报率预期。</p>
<ul>
<li>在我们的详细增长预测报告中深入了解 Chroma ATE 的具体情况。</li>
<li>根据我们最近的估值报告，Chroma ATE 的交易价格似乎超出了其估计价值。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0015e6b6-6fe9-4a56-9d8e-dc84ebdc9313/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0015e6b6-6fe9-4a56-9d8e-dc84ebdc9313/chart/ownership-breakdown"/></p>
<p>TWSE:2360 截至 2025 年 10 月的持股结构</p>
<h2>利用机会</h2>
<ul>
<li>点击这里解锁我们全面的 819 家高内部持股的快速增长全球公司的名单。</li>
<li>准备好不同的方式了吗？人工智能即将改变医疗保健。这 33 只股票正在从早期诊断到药物发现的各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式引用，时间范围为 1-3 年。</em></p>

锐明技术

微导纳米

北京君正

<p>在 2025 年 10 月，全球市场正经历低于预期的美国通胀和波动的国债收益率，这促使投资者关注内部持股比例较高的成长型公司。值得注意的公司包括锐明技术、Seers Technology 和 KebNi，内部持股比例在 11.9% 到 36.3% 之间，盈利增长在 24.9% 到 91.9% 之间。江苏微导纳米和北京君正尽管股价波动，但显示出强劲的增长潜力。文章强调了内部持股作为不确定经济条件下稳定因素的重要性</p>

<p>In October 2025, global markets are navigating a complex landscape marked by lower-than-expected U.S. inflation, fluctuating Treasury yields, and strengthening business activity across key regions such as the Eurozone and China. Amid these developments, investors are increasingly focusing on growth companies with high insider ownership as a potential avenue for stability and resilience in an uncertain economic environment.</p>
<div class="lb-trans"><p>在 2025 年 10 月，全球市场正面临一个复杂的局面，特点是美国通胀低于预期、国债收益率波动，以及欧元区和中国等关键地区的商业活动增强。在这些发展中，投资者越来越关注内部持股比例高的成长型公司，作为在不确定经济环境中寻求稳定和韧性的潜在途径。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership Globally</h3>
<div class="lb-trans"><h3>全球内部持股比例高的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>84.6%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.9%</td>
<td>43.9%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>30.3%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>34.2%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>69.2%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>24.9%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>35.2%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>49.6%</td>
</tr>
<tr>
<td>Ascentage Pharma Group International (SEHK:6855)</td>
<td>12.8%</td>
<td>91.9%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>锐明技术 (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>84.6%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.9%</td>
<td>43.9%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>30.3%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>34.2%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>69.2%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>24.9%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>35.2%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>49.6%</td>
</tr>
<tr>
<td>Ascentage Pharma Group International (SEHK:6855)</td>
<td>12.8%</td>
<td>91.9%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 819 stocks from our Fast Growing Global Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们筛选出的 819 只内部持股比例高的快速成长全球公司的完整名单。</p>
</div><p>Underneath we present a selection of stocks filtered out by our screen.</p>
<div class="lb-trans"><p>以下是我们筛选出的部分股票。</p>
</div><h2>Jiangsu Leadmicro Nano-Equipment Technology (SHSE:688147)</h2>
<div class="lb-trans"><h2>江苏微导纳米设备科技 (SHSE:688147)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Jiangsu Leadmicro Nano-Equipment Technology Ltd specializes in manufacturing high-end micro-nano equipment for semiconductor and pan-semiconductor industries, with a market cap of CN¥24.40 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 江苏微导纳米设备科技有限公司专注于制造高端微纳米设备，服务于半导体及泛半导体行业，市值为 244 亿元人民币。</p>
</div><p><strong>Operations:</strong> The company generates revenue of CN¥2.96 billion from its equipment manufacturing segment, focusing on high-end micro-nano equipment for semiconductor and pan-semiconductor sectors.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司通过设备制造部门产生收入，专注于半导体及泛半导体领域的高端微纳米设备。</p>
</div><p><strong>Insider Ownership:</strong> 18.7%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 18.7%</p>
</div><p>Jiangsu Leadmicro Nano-Equipment Technology exhibits strong growth potential, with earnings forecasted to increase significantly over the next three years. The company's revenue is expected to grow at 22.7% annually, outpacing the Chinese market average. Despite a high price-to-earnings ratio of 68.7x, it remains below the semiconductor industry average of 80.6x. Recent financial performance shows substantial improvement, with net income rising to CNY 192.36 million for H1 2025 from CNY 42.85 million last year, underscoring its growth trajectory amidst volatile share prices and completed share buybacks totaling CNY 79.53 million.</p>
<div class="lb-trans"><p>江苏微导纳米设备科技展现出强劲的增长潜力，预计未来三年收益将显著增长。公司的收入预计将以 22.7% 的年率增长，超过中国市场的平均水平。尽管市盈率高达 68.7 倍，但仍低于半导体行业的平均水平 80.6 倍。最近的财务表现显示出显著改善，2025 年上半年净收入从去年的 4285 万元上升至 1.9236 亿元，突显出其在股价波动和完成总计 7953 万元的股票回购中的增长轨迹。</p>
</div><ul>
<li>Navigate through the intricacies of Jiangsu Leadmicro Nano-Equipment Technology with our comprehensive analyst estimates report here.</li>
<li>Insights from our recent valuation report point to the potential overvaluation of Jiangsu Leadmicro Nano-Equipment Technology shares in the market.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过我们的综合分析师估计报告深入了解江苏微导纳米设备科技的复杂性。</li>
<li>我们最近的估值报告指出，江苏微导纳米设备科技的股票在市场上可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b4b45422-b4d0-4f2a-8c1b-61597995333c/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/b4b45422-b4d0-4f2a-8c1b-61597995333c/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:688147 Earnings and Revenue Growth as at Oct 2025</p>
<div class="lb-trans"><p>SHSE:688147 截至 2025 年 10 月的收益和收入增长</p>
</div><h2>Ingenic SemiconductorLtd (SZSE:300223)</h2>
<div class="lb-trans"><h2>北京君正半导体有限公司 (SZSE:300223)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Ingenic Semiconductor Co., Ltd. focuses on the research, development, design, and sale of integrated circuit chip products both in China and internationally, with a market cap of CN¥43.42 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 北京君正半导体有限公司专注于集成电路芯片产品的研发、设计和销售，业务覆盖中国及国际市场，市值为 434.2 亿元人民币。</p>
</div><p><strong>Operations:</strong> Ingenic Semiconductor Co., Ltd. generates revenue through the research, development, design, and sale of integrated circuit chip products across domestic and international markets.</p>
<div class="lb-trans"><p><strong>运营：</strong> 北京君正半导体有限公司通过在国内外市场的集成电路芯片产品的研发、设计和销售产生收入。</p>
</div><p><strong>Insider Ownership:</strong> 16%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 16%</p>
</div><p>Ingenic Semiconductor Ltd. demonstrates potential with earnings projected to grow significantly at 26.43% annually, surpassing the Chinese market average. However, its share price has been highly volatile recently. Despite this volatility, recent amendments to company bylaws and plans for an H-share offering in Hong Kong suggest strategic growth initiatives. The company's half-year 2025 financials show modest revenue and net income increases to CNY 2.25 billion and CNY 203.12 million respectively, indicating steady performance amidst these developments.</p>
<div class="lb-trans"><p>北京君正半导体有限公司展现出潜力，预计收益将以 26.43% 的年率显著增长，超过中国市场的平均水平。然而，其股价近期波动较大。尽管如此，最近对公司章程的修订和在香港进行 H 股发行的计划表明了战略增长的举措。公司的 2025 年半年度财务数据显示，收入和净收入分别小幅增长至 22.5 亿元和 2.0312 亿元，表明在这些发展中的稳定表现。</p>
</div><ul>
<li>Take a closer look at Ingenic SemiconductorLtd's potential here in our earnings growth report.</li>
<li>The analysis detailed in our Ingenic SemiconductorLtd valuation report hints at an inflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的收益增长报告中更深入地了解北京君正半导体有限公司的潜力。</li>
<li>我们的北京君正半导体有限公司估值报告中的分析暗示其股价相较于估计价值被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/acde7488-b0a5-45e4-9f1d-446e3fdc5877/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/acde7488-b0a5-45e4-9f1d-446e3fdc5877/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300223 Earnings and Revenue Growth as at Oct 2025</p>
<div class="lb-trans"><p>SZSE:300223 截至 2025 年 10 月的收益和收入增长</p>
</div><h2>Chroma ATE (TWSE:2360)</h2>
<div class="lb-trans"><h2>Chroma ATE (TWSE:2360)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Chroma ATE Inc. is a company that designs, assembles, manufactures, sells, repairs, and maintains various software and hardware products including computerized automatic test systems and electronic test instruments across Taiwan, China, the United States, and internationally; it has a market cap of NT$293.18 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Chroma ATE Inc.是一家设计、组装、制造、销售、维修和维护各种软件和硬件产品的公司，包括计算机自动测试系统和电子测试仪器，业务遍及台湾、中国、美国及国际市场；市值为 2931.8 亿新台币。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its Measuring Instruments Business, which generates NT$39.77 billion, and Automated Transport Engineering, contributing NT$1.32 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其测量仪器业务，产生 397.7 亿新台币，以及自动化运输工程，贡献 13.2 亿新台币。</p>
</div><p><strong>Insider Ownership:</strong> 14.6%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 14.6%</p>
</div><p>Chroma ATE's growth trajectory is underscored by a forecasted earnings increase of 19.24% annually, outpacing the Taiwan market average. Despite recent share price volatility, its robust financial performance in Q2 2025—highlighted by revenue rising to TWD 6.46 billion and net income reaching TWD 1.95 billion—demonstrates resilience. While insider trading activity remains stable with no significant buying or selling, the company maintains a strong Return on Equity forecast of 32.5% in three years.</p>
<div class="lb-trans"><p>Chroma ATE 的增长轨迹通过预计年收益增长 19.24% 得以体现，超过台湾市场的平均水平。尽管近期股价波动较大，但其 2025 年第二季度的强劲财务表现——收入上升至 64.6 亿新台币，净收入达到 19.5 亿新台币——显示出韧性。尽管内部交易活动保持稳定，没有显著的买入或卖出，但公司在三年内保持 32.5% 的强劲股本回报率预期。</p>
</div><ul>
<li>Dive into the specifics of Chroma ATE here with our thorough growth forecast report.</li>
<li>In light of our recent valuation report, it seems possible that Chroma ATE is trading beyond its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的详细增长预测报告中深入了解 Chroma ATE 的具体情况。</li>
<li>根据我们最近的估值报告，Chroma ATE 的交易价格似乎超出了其估计价值。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0015e6b6-6fe9-4a56-9d8e-dc84ebdc9313/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/0015e6b6-6fe9-4a56-9d8e-dc84ebdc9313/chart/ownership-breakdown"/></p>
<p>TWSE:2360 Ownership Breakdown as at Oct 2025</p>
<div class="lb-trans"><p>TWSE:2360 截至 2025 年 10 月的持股结构</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用机会</h2>
</div><ul>
<li>Unlock our comprehensive list of 819 Fast Growing Global Companies With High Insider Ownership by clicking here.</li>
<li>Ready For A Different Approach? AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里解锁我们全面的 819 家高内部持股的快速增长全球公司的名单。</li>
<li>准备好不同的方式了吗？人工智能即将改变医疗保健。这 33 只股票正在从早期诊断到药物发现的各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式引用，时间范围为 1-3 年。</em></p>
</div>

2025 年 10 月内部持股比例高的全球增长型公司